Call Content
 
     
 

The Call for Ethical Clinical Trials in Developing Countries has been formulated out of concern about the shift in many clinical drug trials away from the richer nations and towards developing countries, and the associated ethical violations. It represents a call to action for policy makers, regulators and pharmaceutical companies to protect vulnerable trial subjects and it has been signed by leading figures in the field of medicine and ethics, and other concerned parties. The call was drafted by a worldwide coalition of health and human rights organizations and experts led by the Wemos Foundation. 

Featured Content

German media pay attention to Wemos' work on fair drugs
Click here to read more...

Ethics: from the shadows to the spotlight
Click here to read more...

Barbara from Poland narrates about the medical trial her son participated in
Click here to read more...

Testimonies from Human Subjects
Click here to read more...

'Everything is political'
Click here to read more...

'People have to insist on fair drugs'
Click here to read more...

They signed the Call
Click here to read more...

Watchdog for Latin America
Click here to read more...

 

 

Subscribe
Keep up to date by subscribing to our e-mail newsletter.
 
  security code  
  To prevent automated subscriptions please enter the Security Code above:  
   
 


Call for Ethical Clinical Trials
in Developing Countries

c/o Wemos Foundation
Ellermanstraat 15-O
P.O. Box 1693
1000 BR Amsterdam
The Netherlands
Phone +31 20 435 20 50
Site www.wemos.nl
E-mail info@wemos.nl